BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
BioInvent International Price to Book Value: 2.673 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.673 |
| May 03, 2024 | 2.673 |
| May 02, 2024 | 2.673 |
| May 01, 2024 | 2.673 |
| April 30, 2024 | 2.673 |
| April 29, 2024 | 2.673 |
| April 26, 2024 | 2.673 |
| April 25, 2024 | 2.673 |
| April 24, 2024 | 2.673 |
| April 23, 2024 | 2.673 |
| April 22, 2024 | 2.673 |
| April 19, 2024 | 2.673 |
| April 18, 2024 | 2.673 |
| April 17, 2024 | 2.673 |
| April 16, 2024 | 2.673 |
| April 15, 2024 | 2.673 |
| April 12, 2024 | 2.673 |
| April 11, 2024 | 2.673 |
| April 10, 2024 | 2.673 |
| April 09, 2024 | 2.673 |
| April 08, 2024 | 2.673 |
| April 05, 2024 | 2.673 |
| April 04, 2024 | 2.673 |
| April 03, 2024 | 2.673 |
| April 02, 2024 | 2.673 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.673 |
| March 31, 2024 | |
| March 28, 2024 | 2.377 |
| March 27, 2024 | 2.377 |
| March 26, 2024 | 2.377 |
| March 25, 2024 | 2.377 |
| March 22, 2024 | 2.377 |
| March 21, 2024 | 2.377 |
| March 20, 2024 | 2.377 |
| March 19, 2024 | 2.377 |
| March 18, 2024 | 2.377 |
| March 15, 2024 | 2.377 |
| March 14, 2024 | 2.377 |
| March 13, 2024 | 2.377 |
| March 12, 2024 | 2.377 |
| March 11, 2024 | 2.377 |
| March 08, 2024 | 2.377 |
| March 07, 2024 | 2.377 |
| March 06, 2024 | 2.377 |
| March 05, 2024 | 2.377 |
| March 04, 2024 | 2.377 |
| March 01, 2024 | 2.377 |
| February 29, 2024 | 2.377 |
| February 28, 2024 | 2.377 |
| February 27, 2024 | 2.377 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.153
Minimum
Jan 27 2022
7.914
Maximum
May 29 2019
2.643
Average
2.275
Median
Jun 30 2023
Price to Book Value Benchmarks
| Abliva AB | 1.914 |
| Karolinska Development AB | 0.5938 |
| Calliditas Therapeutics AB | 16.24 |
| Oncopeptides AB | 1.961 |
| Olink Holding AB | 5.747 |
Price to Book Value Related Metrics
| PS Ratio | 53.90 |
| PEG Ratio | -0.0046 |
| Price | 4.70 |
| Earnings Yield | -10.22% |
| Market Cap | 309.28M |
| PEGY Ratio | -0.0046 |